Phosphate supplementation for low phosphate in ICU patients
Part of Hormones & metabolism clinical trials.
This trial tests whether adding phosphate granules to feeding tubes can help raise low phosphate levels in ICU patients who are already receiving nutrition through a feeding tube.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You are currently in the ICU with low phosphate levels (below 0.80 mmol/L) and your doctor has decided you need phosphate.
- You are getting at least 10 calories per kilogram of body weight per day through a feeding tube.
- You are not pregnant or breastfeeding.
- You do not have any stomach or bowel problems that would prevent using a feeding tube (like a blockage, severe pancreatitis, or intolerance).
- You do not have severe kidney problems, a known allergy to the study drug, or other conditions that make participation unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a standard way to replace phosphate in adult intensive care patients to see if it improves outcomes. If you are in the ICU, you may be eligible to join.
This study looks at how low phosphate levels in the blood affect your ability to breathe on your own when coming off a ventilator. If you are already getting better and ready to start breathing without the machine, the results may help doctors understand and manage your recovery better.
This early study looks at how the body’s handling of phosphate may affect aging and bone health. It is meant for people with certain rare genetic conditions that change phosphate levels, to better understand their biology and responses to study tests.
This trial tests if giving phosphate through a vein can help people with acute pancreatitis. It's for adults who come to the emergency room with pancreatitis and can start treatment within 24 hours of being admitted to the hospital.
This trial compares two treatment goals for blood phosphate levels in people with end-stage kidney disease who are on dialysis. It may help determine which target is safer and works better in real-world care.
This trial tests a new drug called AP301 to lower high phosphate levels in people on dialysis. It's designed to help control phosphate, which can be hard to manage with diet and current medications.
Hear when a new Hypophosphatemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.